Back

Spironolactone in atrial fibrillation with preserved cardiac contractility

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late Breaking Science in Heart Failure 1 Heart Failure in Atrial Fibrillation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Eduard Shantsila

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Effects of Sacubitril-Valsartan Compared with Enalapril on Arterial Hemodynamics and Cardiac Remodeling in Patients with Heart Failure and Reduced Ejection Fraction
Doctor A. Desai (Boston, US)
Slides Video
Presentation thumbnail
Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on NT-proBNP and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: Primary Results of the PROVE-HF Study
Professor J. Januzzi (Boston, US)
Slides Video
Presentation thumbnail
Clinical effectiveness of primary prevention implantable defibrillators: results of the EU-CERT-ICD non-randomised, controlled, multicentre study
Associate Professor M. Zabel (Goettingen, DE)
Slides Video
Presentation thumbnail
Clinical phenotypes, gender differences and adverse events associated with truncating variants in the Titin (TTN) gene
Doctor M. Akhtar (London, GB)
Slides Video

Access the full session

Session thumbnail
Late Breaking Science in Heart Failure 1

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources